SCHEMBL14083216

SCHEMBL14083216

CCCCc1ccc(NC(=O)c2ccc(-c3ncccc3Cl)cc2NC)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 1/20 0.49
▸ TRPV1 Q8NER1 6/20 0.47
▸ NPC1 O15118 3/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ NFKB1 P19838 1/20 0.47
▸ NFKB2 Q00653 1/20 0.47
▸ RELA Q04206 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ PRSS12 P56730 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ CASP3 P42574 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ SENP8 Q96LD8 1/20 0.43
▸ SENP7 Q9BQF6 1/20 0.43
▸ SENP6 Q9GZR1 1/20 0.43
▸ NR3C1 P04150 1/20 0.43
▸ MAPT P10636 1/20 0.42
▸ TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083169 0.88 KDR (0.54) KDRTRPV1NPC1RAB9AALDH1A1
SCHEMBL14083332 0.88 KDR (0.47) KDRTRPV1NPC1RAB9AALDH1A1
SCHEMBL14083359 0.88 TRPV1 (0.52) KDRTRPV1NPC1RAB9AALDH1A1
SCHEMBL14083605 0.88 TRPV1 (0.53) KDRTRPV1NPC1RAB9AALDH1A1
SCHEMBL14083192 0.86 TRPV1 (0.54) TRPV1NPC1RAB9AMEN1KMT2A
SCHEMBL14083203 0.85 TRPV1 (0.52) TRPV1ALDH1A1MEN1KMT2AMAPT
SCHEMBL14083185 0.85 TRPV1 (0.48) TRPV1NPC1RAB9AALDH1A1NFKB1
SCHEMBL14083213 0.83 TRPV1 (0.53) TRPV1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL4590986 0.83 TRPV1 (0.67) TRPV1NPC1RAB9AALDH1A1NFKB1
SCHEMBL14083229 0.83 TRPV1 (0.47) TRPV1NPC1RAB9AALDH1A1NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 KDR 2604/4885TRPV1 1/4885NPC1 1061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback